Clinical Research Directory
Browse clinical research sites, groups, and studies.
Low Dose Edoxaban in Elderly Patients With AF and a History of Stroke
Sponsor: National Taiwan University Hospital
Summary
This prospectively enrolled, pragmatic randomized trial aims to investigate whether very low dose edoxaban regimen (15 mg daily) achieves similar edoxaban concentrations as low dose edoxaban regimen (30 mg daily), while maintaining a comparable risk of clinical outcomes and reducing major bleeding in elderly patients with atrial fibrillation and a history of ischemic stroke or transient ischemic attack.
Official title: Low-Dose Edoxaban Versus Very-Low-Dose Edoxaban in Elderly Patients With Atrial Fibrillation and a History of Stroke (LEAVE-Stroke): A Pragmatic Randomized Clinical Trial
Key Details
Gender
All
Age Range
80 Years - Any
Study Type
INTERVENTIONAL
Enrollment
300
Start Date
2025-04-01
Completion Date
2030-12-31
Last Updated
2025-04-02
Healthy Volunteers
No
Interventions
edoxaban
edoxaban 15 mg daily will be administered to the patients as secondary stroke prevention.
Edoxaban 30 mg
edoxaban 30 mg daily will be administered to the patients as secondary stroke prevention.
Locations (1)
National Taiwan University Hospital
Taipei, Taiwan